GANGAGEN BIOTECHNOLOGIES
Biotech startups turn chary as AstraZeneca shuts R&D unitNearly half a dozen startups trace their roots to the 25-year-old centre that led critical research in areas such as tuberculosis and malar...12 Feb, 2014, 03.25 AM IST
Load More